Back

Large-Scale Evaluation of the Positive and Negative Syndrome Scale (PANSS) Symptom Architecture in Schizophrenia

Lim, K.; Peh, O.-H.; Yang, Z.; Rekhi, G.; Rapisarda, A.; See, Y.-M.; Abdul Rashid, N. A.; Ang, M.-S.; Lee, S.-A.; Sim, K.; Huang, H.; Lencz, T.; Lee, J.; Lam, M.

2020-08-13 psychiatry and clinical psychology
10.1101/2020.08.10.20170662
Show abstract

Although the Positive and Negative Syndrome Scale (PANSS) is widely utilized in schizophrenia research, variability in specific item loading exist, hindering reproducibility and generalizability of findings across schizophrenia samples. We aim to establish a common metric PANSS factor structure from a large multi-ethnic sample and validate it against a meta-analysis of existing PANSS models. Schizophrenia participants (N = 3511) included in the current study were part of the Singapore Translational and Clinical Research Program (STCRP) and the Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE). Exploratory Factor Analysis (EFA) was conducted to identify the factor structure of PANSS and validated with a meta-analysis (N = 16,171) of existing PANSS models. Temporal stability of the PANSS model and generalizability to individuals at ultra-high risk (UHR) of psychosis were evaluated. A five-factor solution best fit the PANSS data. These were the i) Positive, ii) Negative, iii) Cognitive/disorganization, iv) Depression/anxiety and v) Hostility factors. Convergence of PANSS symptom architecture between EFA model and meta-analysis was observed. Modest longitudinal reliability was observed. The schizophrenia derived PANSS factor model fit the UHR population, but not vice versa. We found that two other domains, Social Amotivation (SA) and Diminished Expression (DE), were nested within the negative symptoms factor. Here, we report one of the largest transethnic factorial structures of PANSS symptom domains (N = 19,682). Evidence reported here serves as crucial consolidation of a common metric PANSS that could aid in furthering our understanding of schizophrenia.

Matching journals

1
Schizophrenia Bulletin
Oxford University Press (OUP) · based on 21 published papers
#1
203× avg
2
Schizophrenia Research
Elsevier BV · based on 11 published papers
#1
323× avg
3
Schizophrenia
Springer Science and Business Media LLC · based on 13 published papers
#1
202× avg
4
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 65%
5.6%
5
Biological Psychiatry
Elsevier BV · based on 36 published papers
Top 2%
12× avg
6
Psychological Medicine
Cambridge University Press (CUP) · based on 52 published papers
Top 4%
8.3× avg
7
Translational Psychiatry
Springer Science and Business Media LLC · based on 94 published papers
Top 5%
5.2× avg
8
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 59%
2.6%
9
Psychiatry Research
Elsevier BV · based on 33 published papers
Top 3%
10× avg
10
BMC Psychiatry
Springer Science and Business Media LLC · based on 20 published papers
Top 0.9%
21× avg
11
Molecular Psychiatry
Springer Science and Business Media LLC · based on 84 published papers
Top 5%
4.9× avg
12
Journal of Psychiatric Research
Elsevier BV · based on 22 published papers
Top 2%
16× avg
13
Neuroscience & Biobehavioral Reviews
Elsevier BV · based on 19 published papers
Top 3%
7.9× avg
14
Neuropsychopharmacology
Springer Science and Business Media LLC · based on 29 published papers
Top 3%
6.2× avg
15
The British Journal of Psychiatry
Royal College of Psychiatrists · based on 21 published papers
Top 3%
5.4× avg
16
NeuroImage: Clinical
Elsevier BV · based on 77 published papers
Top 8%
1.9× avg